These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 7198139
1. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies. Köhler C, Haglund L, Ogren SO, Angeby T. J Neural Transm; 1981; 52(3):163-73. PubMed ID: 7198139 [Abstract] [Full Text] [Related]
2. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors. Köhler C, Ogren SO, Haglund L, Angeby T. Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522 [Abstract] [Full Text] [Related]
3. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats. Jenner P, Rupniak NM, Marsden CD. Psychopharmacology Suppl; 1985 Jun; 2():174-81. PubMed ID: 3159009 [Abstract] [Full Text] [Related]
4. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats. Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD. Psychopharmacology (Berl); 1984 Jun; 84(4):512-9. PubMed ID: 6441952 [Abstract] [Full Text] [Related]
5. Studies on the mechanism of action of substituted benzamide drugs. Köhler C, Ogren SO, Fuxe K. Acta Psychiatr Scand Suppl; 1984 Jun; 311():125-37. PubMed ID: 6142588 [Abstract] [Full Text] [Related]
6. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation. Chivers JK, Reavill C, Jenner P, Marsden CD. J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027 [Abstract] [Full Text] [Related]
7. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. Ogren SO, Hall H, Köhler C, Magnusson O, Lindbom LO, Angeby K, Florvall L. Eur J Pharmacol; 1984 Jul 20; 102(3-4):459-74. PubMed ID: 6149133 [Abstract] [Full Text] [Related]
8. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat. Lai H, Carino MA, Horita A. Psychopharmacology (Berl); 1981 Jul 20; 75(4):388-90. PubMed ID: 6122233 [Abstract] [Full Text] [Related]
9. Effects of chronic haloperidol, thioridazine and zotepine treatment on apomorphine elicited stereotypic behavior and 3H-spiroperidol binding sites in the striatum of the rat. Lai HC, Carino MA, Horita A. Proc West Pharmacol Soc; 1981 Jul 20; 24():5-6. PubMed ID: 6114496 [No Abstract] [Full Text] [Related]
10. Definition of the in-vivo binding of [3H]spiperone in rat brain using substituted benzamide drugs. Chivers JK, Reavill C, Jenner P, Marsden CD. J Pharm Pharmacol; 1989 Feb 20; 41(2):106-11. PubMed ID: 2568417 [Abstract] [Full Text] [Related]
11. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions. List SJ, Seeman P. Proc Natl Acad Sci U S A; 1981 Apr 20; 78(4):2620-4. PubMed ID: 6941314 [Abstract] [Full Text] [Related]
19. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Rupniak NM, Mann S, Hall MD, Fleminger S, Kilpatrick G, Jenner P, Marsden CD. Psychopharmacology (Berl); 1984 Apr 20; 84(4):503-11. PubMed ID: 6441951 [Abstract] [Full Text] [Related]
20. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. Florijn WJ, Tarazi FI, Creese I. J Pharmacol Exp Ther; 1997 Feb 20; 280(2):561-9. PubMed ID: 9023264 [Abstract] [Full Text] [Related] Page: [Next] [New Search]